- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Canopy Growth Corp (C:WEED) Shares Issued 159,227,298 Last Close 3/13/2017 $11.13Tuesday March 14 2017 – News Release Mr. Mark Zekulin reports TWEED’S HOMEGROW COLLECTION NOW AVAILABLE Canopy Growth Corp.’s Tweed Inc. has launched sales of a variety of top-tier seeds, under its HomeGrow Collection banner. Consisting of 10 cannabis varieties ranging from low and high …
Shares Issued 159,227,298
Last Close 3/13/2017 $11.13
Tuesday March 14 2017 – News Release
Mr. Mark Zekulin reports
TWEED’S HOMEGROW COLLECTION NOW AVAILABLE
Canopy Growth Corp.’s Tweed Inc. has launched sales of a variety of top-tier seeds, under its HomeGrow Collection banner. Consisting of 10 cannabis varieties ranging from low and high tetrahydrocannabinol to cannabidiol options, the HomeGrow Collection is designed to meet the needs of a variety of patients managing a variety of symptoms.
“Our goal is to offer a wide selection of cannabis products in a variety of formats, from dried bud and blends, to oils,” said Mark Zekulin, president of Canopy Growth, Tweed’s parent company. “We know there is demand for high-quality cannabis seeds and we have long supported the patient’s individual right to grow their own medicine so this is a special day for our company.”
In addition to seeds, Tweed will offer authorized patients a stable interim supply of medical cannabis starting with a one-time $25 discount toward any available product in the Tweed shop.
Home growing was not a part of the regulatory framework for the first few years of Tweed’s operations, but became possible after activists and legal advocates fought to have it reintroduced into the federal regulations.
While the company is supportive of any patient choosing to grow at home, its primary focus remains on supplying ready-to-consume cannabis products to the rapidly growing number of Canadians choosing the convenience and quality that comes from Tweed’s focus on producing the best possible cannabis under the strictest controls and care.
Here’s to future growth.
Canopy Growth is a world-leading diversified cannabis company, offering diverse brands and curated cannabis strain varieties in dried and oil extract forms. Through its wholly owned subsidiaries, Canopy Growth operates numerous state-of-the-art production facilities with over 500,000 square feet of indoor and greenhouse production capacity.
We seek Safe Harbor.
© 2017 Canjex Publishing Ltd.
This email was sent to you at clientpr@
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.